A KAIST research team identified core gene expression networks regulated by proteins that drive phenomena such as cancer development and tissue differentiation. The study revealed that IPMK acts as a critical transcriptional activator in these networks, enhancing SRF's protein activity.
A new study suggests that stalled amyloid protein production contributes to the development of Alzheimer's disease. Researchers found that rare familial genetic mutations linked to early-onset dementia cause deficiencies in multiple APP processing steps, leading to neurodegeneration.
Scientists at St. Jude Children's Research Hospital have designed novel PXR inhibitors that can block the activity of pregnane X receptor, a key regulator of drug metabolism. The study provides new insights into the relationship between compounds that activate and inhibit PXR, with implications for designing more effective therapeutics.
A research team discovered that alpha-synuclein activates the plasma membrane calcium pump in negatively charged environments, preventing toxic cell buildup. This understanding has profound implications for unraveling early Parkinson's disease processes and potential diagnostic and therapeutic strategies.
Researchers discovered a malaria protein, PfAP2-P, that plays a key regulatory role in immune evasion and parasite development. This protein acts as an activator of proteins required for the parasite to exit infected red blood cells and invade new ones.
A study led by Weill Cornell Medicine researchers found that some ion channels can rearrange into a larger structure, enabling drug delivery. The discovery solves a long-standing mystery about ion channel dynamics and has implications for pharmaceuticals.
A team of KAUST researchers has found a critical protein that regulates cell division and proliferation in breast cancer and leukemia. Their work clears the way for the development of targeted drugs by refuting recent challenges to their approach.
The study of ToxR's protein structure bound to DNA has revealed how it triggers cholera toxin production. The research provides insights into the molecular mechanism behind Vibrio cholerae's virulence, shedding light on potential treatments for this disease.
Researchers investigated the roles of STAT3α and STAT3β in aggressive breast cancer and found that differential silencing of these isoforms leads to changes in STAT3 activation. This study emphasizes the importance of distinguishing between STAT3 isoforms for accurate cancer diagnosis and therapy.
Pusan National University researchers have identified a novel gene, SURF4, that regulates cell death and differentiation in acute myeloid leukemia (AML). The study found that suppressing SURF4 expression increases cell differentiation, cell death, and accumulation of ROS, leading to arrested tumor growth in mice.
A recent study discovered a link between soluble urokinase plasminogen activator receptor (suPAR) and the development of atherosclerosis, a hardening of arteries that affects over a billion people worldwide. SuPAR was found to cause inflammation in blood vessels, leading to cardiovascular events and increasing risk of heart disease.
Scientists at the University of Bath have developed a new technique called Transcription Block Survival (TBS) to accelerate the discovery of cancer-fighting drugs. TBS identifies molecules that can shut down dangerous proteins before they wreak havoc, by blocking their interaction with cell DNA.
A team of researchers has identified over 250 gene activators in human cells, expanding our understanding of transcriptional regulation and its role in cancer. The study also reveals new insights into how proteins interact with each other to regulate gene expression, potentially leading to the development of targeted therapies.
A study by Carnegie Mellon University researchers reveals that bacteria have retained the same 'password' for sporulation since its evolution 2.7 billion years ago. The discovery challenges traditional theories on evolution and highlights the persistence of ancient signaling networks in these organisms.
Biochemists have made a discovery that sheds light on the molecular machinery that allows some cells to wiggle their way through tissues. The researchers identified two locations on Arp2/3 where an activator protein touches, promoting cell motility and potentially leading to new opportunities for cancer treatment.
Researchers at UNC Health Care have identified the crystal structure of a key protein interaction involved in cancer cell spread. This discovery aims to develop targeted therapies against invasive cancer cells with minimal side effects.
Researchers at UT Southwestern Medical Center discovered a new protein, SMAC, which promotes apoptosis and is responsible for cell death. The study found that only seven amino acids are necessary to induce cell death, making it possible to design drugs based on these amino acids.
A study found that the plasmin system, which regulates blood clots, may also play a role in Alzheimer's disease. The researchers suggest that destroying amyloid-beta protein deposits with tPA could be a potential treatment for the disease. Further research is needed to confirm this model and explore its effectiveness.
UT Southwestern researchers have created a novel protein cross-linking method that utilizes brief exposure to visible light to initiate bonding between proteins. This technique is about 1,000 times more efficient than existing chemical methods and allows for precise control over the reaction timing.
Researchers at Rockefeller University have determined the three-dimensional structure of Hck, a cancer-causing protein that plays a key role in regulating cell behavior. The study reveals that the protein's shape is controlled by the SH3 domain, which enables it to transform cells into cancerous ones.